Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis (Q81284330)
Jump to navigation
Jump to search
scientific article published on 01 January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis |
scientific article published on 01 January 2005 |
Statements
Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis (English)
Alan Menter
Kenneth Gordon
Wayne Carey
Tiffani Hamilton
Scott Glazer
Ivor Caro
Nicole Li
Wayne Gulliver
1 January 2005